Steffimycin E, a new anti-mycobacterial agent against Mycobacterium avium complex, produced by Streptomyces sp. OPMA02852.
J Antibiot (Tokyo)
; 73(8): 581-584, 2020 08.
Article
em En
| MEDLINE
| ID: mdl-32132675
The marine actinomycete strain OPMA02852, identified as the genus Streptomyces, was found to produce anti-mycobacterial compounds against Mycobacterium avium complex (MAC). One new compound, designated as steffimycin E (1), was isolated together with three known steffimycins (steffimycin (2), 10-dihydrosteffimycin (3), and 8-demethoxysteffimycin (4)) from the culture broth of this producing microorganism by solvent extraction, ODS column chromatography, and preparative HPLC. Compound 1 has a tetracyclic quinone structure with a sugar moiety. Compound 1 exhibited anti-mycobacterial activity against M. intracellulare, M. bovis BCG, and M. smegmatis.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Streptomyces
/
Complexo Mycobacterium avium
/
Antraciclinas
/
Mycobacterium avium
/
Antituberculosos
Limite:
Humans
Idioma:
En
Revista:
J Antibiot (Tokyo)
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Japão